ADRO Stock Price, News & Analysis

ADRO

Company Description

ADRO (Nasdaq: ADRO) is a publicly traded company.

ADRO stock has gained 1290.0% over the past year.

This page provides a comprehensive overview of ADRO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+1290%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

ADRO (ADRO) stock. Over the past 12 months, the stock has gained 1290.0%.

Latest News

View All

October 1, 2020

+389.86%

Aduro Biotech Stockholders Approve Merger Agreement with Chinook Therapeutics

acquisition

August 3, 2020

-8.90%

Aduro Biotech Provides Business Update and Reports Second Quarter 2020 Financial Results

earnings

June 24, 2020

-3.42%

Aduro Biotech Announces First Patient Dosed in Phase 1 Study of BION-1301 in IgA Nephropathy

clinical trial

June 2, 2020

-23.74%

Aduro Biotech Presents Nonclinical and Phase 1 Healthy Volunteer Data for BION-1301 at the 57th ERA-EDTA Virtual Congress

clinical trial

June 2, 2020

-23.74%

Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement

acquisition

May 4, 2020

+10.70%

Aduro Biotech Provides Business Update and Reports First Quarter 2020 Financial Results

earnings

ADRO has 6 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, earnings, clinical trial. View all ADRO news →

SEC Filings

View All

No SEC filings available for ADRO.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months